Search Results

AIZN Assurant, Inc. 5.25% Subordinat - Fundamental Analysis

BEARISH
Sign in to save Save this symbol to a watchlist or track a position.
AIZN Stock | Fundamental Analysis & Investment Insights
NYSE N/A N/A
Current Price Live
$20.69
52W High
$22.0
52W Low
$18.01
Overview AI Snowflake Price Valuation Profitability Growth Health

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
N/A
P/E
N/A
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
65%
Analysis Accuracy
The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 1/9, indicating severe deterioration in fundamental performance. The absence of an Altman Z-Score and all key valuation, profitability, and financial health metrics prevents a comprehensive safety assessment, but the extremely low Piotroski score strongly suggests operational and accounting weaknesses. Despite modest positive price momentum over the past year, the lack of transparency in earnings, cash flow, and balance sheet structure creates substantial risk. With no dividend strength, unclear intrinsic value, and insufficient analyst coverage, the investment case lacks a factual foundation.

Key Strengths

Recent price performance shows short-term momentum, with a 9.5% gain over the last 6 months and 2.6% in the past week.
Trading near the upper end of its 52-week range, suggesting some market confidence or technical strength.
Insider sentiment score of 40/100 indicates no extreme selling pressure, though not bullish.
Subordinated debt with a 5.25% coupon may offer income appeal in a stable environment.
No significant red flags related to extreme overvaluation due to lack of standard multiples.

Key Risks

Piotroski F-Score of 1/9 indicates severe financial distress, with likely declining profitability, negative operating cash flow, and deteriorating leverage ratios.
Critical financial data missing (P/E, P/B, ROE, Debt/Equity, Cash Flow), preventing reliable valuation or solvency analysis.
No Altman Z-Score available, leaving bankruptcy risk unquantified and potentially high given the weak Piotroski score.
Dividend Strength is 0/100, indicating no reliable income stream or payout history.
Lack of analyst coverage and target prices suggests low institutional interest and poor information transparency.

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
27
Weak
Value
25
Future
35
Past
50
Health
15
Dividend
10
AI Verdict
High-risk, low-transparency investment with critically weak fundamentals and insufficient data for reliable valuation.
Key drivers: Piotroski F-Score of 1/9, Missing financial and valuation metrics, No analyst coverage, Neutral insider sentiment, Absence of dividend yield
Confidence
60%
Value
25/100

Ref P/E, PEG, Graham Number

Positives
No standout positives identified.
Watchpoints
  • Graham Number is $None
  • All valuation multiples (P/E, P/B, P/S) are N/A
  • No intrinsic value estimate available
Future
35/100

Ref Growth rates

Positives
  • 6M price change of +9.5% suggests some forward momentum
Watchpoints
  • No forward P/E, earnings growth, or revenue growth data
  • No analyst forecasts to assess future expectations
Past
50/100

Ref Historical trends

Positives
  • 1Y price change of +6.2% and 3Y change of +9.4% show modest appreciation
Watchpoints
  • No historical financial data to confirm sustainability of past performance
Health
15/100

Ref Altman Z-Score, Piotroski F-Score

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score: 1/9 (Critically weak)
  • Altman Z-Score: None (Unassessable bankruptcy risk)
  • All financial health ratios (Debt/Equity, Current Ratio) are missing
Dividend
10/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • Dividend Strength: 0/100
  • Dividend Yield: N/A
  • Payout Ratio: N/A
  • No ex-dividend date available

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$20.69

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for AIZN and closest competitors.

Updated 2026-01-23
Company 5Y 3Y 1Y 6M 1M 1W
AIZN
Assurant, Inc. 5.25% Subordinat
Primary
 +6.2% +9.4% +6.2% +9.5% +6.8% +2.6%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
N/A
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A

Past News Coverage

Recent headlines mentioning AIZN from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V1 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features AI Console AI Assistant Trading Challenge Analysis Market News Pricing
Sign In Get Started
Dashboard AI Chat Analysis Charts Profile